https://www.selleckchem.com/products/dmh1.html
Combinatorial therapies are under intense investigation to develop more efficient anti-obesity drugs; however, little is known about how they act in the brain to produce enhanced anorexia and weight loss. The goal of this study was to identify the brain sites and neuronal populations engaged during the co-administration of GLP-1R and CCK1R agonists, an efficient combination therapy in obese rodents. We measured acute and long-term feeding and body weight responses and neuronal activation patterns throughout the neuraxis and in specific neu
Like
Comment
Share
